John Boyer

John Boyer is an experienced leader in medical affairs with a strong focus on oncology and hematology. Currently serving as the Interim Head of US Medical Affairs at Ipsen, John has held various strategic positions including Head of Hematology and Global Medical Asset Lead for TAZVERIK. Previously at AstraZeneca, John led global medical strategies for ENHERTU and other oncology products, while at Mundipharma, John managed medical affairs across multiple therapy areas. John began a career in medical management at Roche and has a solid academic foundation with a PhD in Molecular Oncology from Queen's University Belfast.